Skip to main content
Equibles

Man Group plc

Position in NUVB — Nuvation Bio Inc.

CIK 1637460 LONDON, X0
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,332,116
-$380,185 QoQ
Shares Held
410,584
-35.1% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 242 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. NUVB ranks #54 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5 APGE
Apogee Therapeutics, Inc.
 397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in NUVB

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,332,116 410,584
2026-03-31 $2,712,301 632,238
2025-09-30 $330,620 89,357
2025-06-30 $75,295 38,613
2024-06-30 $323,027 110,626
2024-03-31 $947,415 260,279
2023-12-31 $359,878 238,330
2022-09-30 $123,424 55,100
2022-06-30 $175,000 53,900
2022-03-31 $76,270 14,500